Farallon Capital Management LLC Equillium, Inc. Transaction History

Farallon Capital Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 17, 2021	SELL	$5.03 - $10.5 $100,600 - $210,000	-20,000 Reduced 2.86%	680,000 $4.86 Million
Q3 2020 Nov 16, 2020	BUY	$2.78 - $26.5 $1.95 Million - $18.6 Million	700,000 New	700,000 $4.04 Million

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.